Alan Kozikowski News Today

Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - December 14, 2023) - PurMinds NeuroPharma ("PurMinds™" or the "Company"), a clinical-stage neuroscience company focused on neurological and neurodegenerative disorders and advancing a robust clinical development pipeline of small molecules, psychedelic compounds and other modalities, is pleased to announce that its management team, including Chief Executive Officer Janet Qi and Chief Scientific Officer Dr. A...

Toronto, Ontario--(Newsfile Corp. - September 28, 2023) - PurMinds NeuroPharma ("PurMinds" or the "Company"), a neuroscience company with a robust clinical pipeline combining small molecules, psychedelic compounds and other modalities, pursuing breakthrough therapeutic solutions for neurological disorders hallmarked by neurodegeneration, today announced completion of acquisition of a small molecule novel chemical entity (NCE) known as SW-200, a non-hydroxamic acid that shows ...

FN Media Group Presents Microsmallcap.com Market Commentary NEW YORK, Oct. 5, 2022 /PRNewswire/ -- A new study undertaken by experts at John Hopkins University School of Medicine has revealed

/PRNewswire/ -- A new study undertaken by experts at John Hopkins University School of Medicine has revealed that taking psychedelics can have the same...

The company is developing the "next generation" of non-addictive psychedelic medicines to treat depression and other neurological conditions...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Biotech companies are using modern technology and the latest science to harness the benefits of the drugs. Numerous studies have shown the efficacy of psilocybin on improving mental health.